<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04309175</url>
  </required_header>
  <id_info>
    <org_study_id>299/T-22</org_study_id>
    <nct_id>NCT04309175</nct_id>
  </id_info>
  <brief_title>Long-term Atrial Pacing and Central Blood Pressure</brief_title>
  <official_title>Effect of Long-term Atrial Pacing on Central Blood Pressure in Permanently Paced Sick Sinus Syndrome Patients With Primary Arterial Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tartu University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>North Estonia Medical Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tartu University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled single-centre clinical trial with a cross-over design to
      compare non-invasively evaluated central blood pressure and related parametres in sick sinus
      syndrome patients with hypertension who are paced long-term at a slower vs faster heart rate
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2020</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>systolic blood pressure amplification change</measure>
    <time_frame>two months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">58</enrollment>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>Slow-Fast</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Fast-Slow</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>base rate programming of a permanent cardiac pacemaker</intervention_name>
    <description>Base rate of a subject`s pacemaker is set to a slower, and after wash-out, to a faster pacing rate (Slow-Fast Arm) or to a faster, and after wash-out, to a slower pacing rate (Fast-Slow Arm)</description>
    <arm_group_label>Fast-Slow</arm_group_label>
    <arm_group_label>Slow-Fast</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-80 years

          -  sick sinus syndrome

          -  permanent cardiac pacemaker with right atrial and right ventricular leads

          -  at least 3 months from implantation

          -  sinus rhythm

          -  percentage of atrial pacing at or above 80% since last interrogation

          -  percentage of ventricular pacing at or below 3% since last interrogation

          -  primary arterial hypertension

          -  antihypertensive drug treatment

          -  mean office brachial blood pressure below 140/90 mmHg

          -  mean home brachial blood pressure below 135/85 mmHg

          -  ability to understand and follow study protocol

          -  signed informed consent form

        Exclusion Criteria:

          -  inclusion criteria not fulfilled

          -  violation of study protocol by subject, investigator or third part

          -  high quality central hemodynamic measurements cannot be perfomed

          -  inter-arm difference in brachial systolic blood pressure 15 mmHg or above

          -  intrinsic QRS complex 130 ms or above

          -  more than three antihypertensive agents in use

          -  treatment with digoxin or agents from Vaughan-Williams classes Ic, III või IV

          -  frequent high atrial rate episodes

          -  coronary artery disease

          -  secondary hypertension

          -  resistant hypertension

          -  orthostatic hypotension

          -  heart failure with decreased or preserved left ventricular ejection fraction

          -  implantable cardioverter-defibrillator or cardiac resynchronization therapy

          -  significant valvular heart disease

          -  significant congenital heart disease

          -  body mass index ≥35 kg/m2

          -  type I diabetes

          -  type II diabetes with cardiovascular complications or on insulin therapy

          -  other significant endocrine disease

          -  history of cerebrovascular attack

          -  carotid artery disease

          -  lower extremity arterial disease

          -  severe chronic obstructive pulmonary disease

          -  severe asthma

          -  severe sleep apnea

          -  interstitial pulmonary disease

          -  inhaled beta adrenergic agonist therapy

          -  active cancer treatment

          -  central nervous system degenerative disease

          -  systemic connective tissue disease

          -  abnormal TSH at present

          -  glomerular filtration rate ≤30 ml/min/m2

          -  hemoglobin &lt;100 g/L (female), &lt;110 g/L (male)

          -  hepatic dysfunction

          -  alcohol abuse

          -  pregnancy or breastfeeding

          -  no health insurance provided by Estonian Health Insurance Fund

          -  withdrawal of informed consent

          -  loss of contact with a subject during study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Priit Kampus, Dr</last_name>
    <phone>+3725200193</phone>
    <email>priit.kampus@regionaalhaigla.ee</email>
  </overall_contact>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 12, 2020</study_first_submitted>
  <study_first_submitted_qc>March 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2020</study_first_posted>
  <last_update_submitted>March 13, 2020</last_update_submitted>
  <last_update_submitted_qc>March 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tartu University Hospital</investigator_affiliation>
    <investigator_full_name>Tuuli Teeäär</investigator_full_name>
    <investigator_title>cardiologist</investigator_title>
  </responsible_party>
  <keyword>central blood pressure</keyword>
  <keyword>sick sinus syndrome</keyword>
  <keyword>pacemaker</keyword>
  <keyword>hypertension</keyword>
  <keyword>sinus node dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sick Sinus Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

